EZSolution™ Dasatinib | 2029

A 100 mM (25 mg in 512 µl) solution of Dasatinib (Cat. No. 1586-25) in anhydrous DMSO.

EZSolution™ Dasatinib is a 100 mM (25 mg in 512 µl) solution of Dasatinib (Cat. No. 1586-25) in anhydrous DMSO.

2029 | EZSolution™ Dasatinib DataSheet

Alternate Name/Synonyms: BMS-354825; Sprycel

Appearance: Liquid

Formulation: A 100 mM solution in DMSO

CAS Number: 302962-49-8

Structure Available?: Yes

Peptide sequence: N/A

Salt Form: No

Molecular Formula: C₂₂H₂₆ClN₇O₂S

Molecular Weight: 488.01

Cell-Permeable?: Yes

Purity: ≥99% by HPLC

Solubilities: N/A

Handling: Protect from air and light

Country of Origin: USA

Tag Line: A multi-kinase inhibitor selective to Bcr-Abl and Src

MDL Number: MFCD11046566

PubChem CID: 3062316

SMILES: CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=NC(=NC(=C3)N4CCN(CC4)CCO)C

InChi: InChI=1S/C22H26ClN7O2S/c1-14-4-3-5-16(23)20(14)28-21(32)17-13-24-22(33- 17)27-18-12-19(26-15(2)25-18)30-8-6-29(7-9-30)10-11-31/h3-5,12-13,31H, 6-11H2,1-2H3,(H,28,32)(H,24,25,26,27)

InChi Key: ZBNZXTGUTAYRHI-UHFFFAOYSA-N